A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
for Ulcerative Colitis
100 locations incl. Birmingham
Sponsor: Takeda
Sex: All·Age: 18 - 80
Code: NCT06581328·Phase 4·Recruiting
Inflammatory bowel disease Clinical Trials in Albuquerque, NM
As of June 2026, 1 paid clinical trial is recruiting for Inflammatory bowel disease in Albuquerque, New Mexico. Inflammatory bowel disease studies test biologics, S1P modulators, and JAK inhibitors for ulcerative colitis and Crohn's disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
1 clinical trial for Inflammatory bowel disease
·Clear filters·↓ Download CSVAbout research studies in Albuquerque
Albuquerque has approximately 362 recruiting research studies across a wide range of therapeutic areas. New Mexico hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Albuquerque
Researchers run research studies in Albuquerque, NM at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of New Mexico Cancer Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Recurrent Endometrial Carcinoma | 94 |
| University of New Mexico | Infant, Small for Gestational Age, Diabetes, Hematologic Tests | 46 |
| Presbyterian Kaseman Hospital | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Chronic Lymphocytic Leukemia | 19 |
| University of New Mexico Health Sciences Center | Interstitial Lung Disease, Severe Alopecia Areata, AVM | 16 |
| University of New Mexico Comprehensive Cancer Center | Cervical Cancer, Cancer, Cancer Risk | 12 |
| Lovelace Medical Center-Saint Joseph Square | Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm, Melanoma | 10 |
| New Mexico Oncology Hematology Consultants | Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Breast Cancer, Cancer | 8 |
| Presbyterian Hospital | Malignant Solid Neoplasm, Adrenal Gland Pheochromocytoma, Aortic Valve Disease | 8 |
| University of New Mexico Hospital | Atrial Fibrillation, Hidradenitis Suppurativa (HS), Intracerebral Hemorrhage | 8 |
| Lovelace Women's Hospital | Malignant Solid Neoplasm, Melanoma, Acute Lymphoblastic Leukemia | 6 |
| Lovelace Radiation Oncology | Extensive Stage Lung Small Cell Carcinoma, Breast Cancer, Limited Stage Lung Small Cell Carcinoma | 5 |
| New Mexico VA Health Care System, Albuquerque, NM | Atherosclerosis, Bipolar Disorder, Chronic Kidney Disease (CKD) Stage 5 | 5 |
| The Mind Research Network | Traumatic Brain Injury, Aging Disorder, Alcohol Use Disorder | 5 |
| University of New Mexico Health Science Center | Adrenal Insufficiency, Arrythmia, Asthma in Children | 5 |
| Albuquerque Clinical Trials, Inc. | Obesity, Overweight, Acute Gout Flare | 4 |
| New Mexico Heart Institute | Atrial Fibrillation, Dilated Cardiomyopathy, Heart Failure With Reduced Ejection Fraction (HFrEF) | 4 |
| Renal Medicine Associates | Antineutrophil Cytoplasmic Antibody-associated Vasculitis, FSGS, Proteinuric Kidney Disease | 3 |
| The University of New Mexico Comprehensive Cancer Center | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Metastatic Breast Cancer | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Albuquerque Rehabilitation and Rheumatology | Arthritis, Psoriatic | 2 |
| Eye Associates of New Mexico, Vision Research Center | Macular Edema Secondary to Inflammation | 2 |
| First Nations Community HealthSource | Hypertension, Suicide Prevention | 2 |
| IMA Clinical Research | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Major Depressive Disorder | 2 |
| IMA Clinical Research - Albuquerque | Alzheimers Disease | 2 |
| Lovelace Health System | Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Pulmonary Embolism | 2 |
Active & Upcoming Studies in Albuquerque (2026)
Recruiting trials in Albuquerque grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (144 active studies)
Cardiovascular (25 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Neurology & pain (20 active studies)
- A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations · Phase 2 · Appello Pharmaceuticals, Inc.
- A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight · Phase 3 · Eli Lilly and Company
Diabetes & metabolic (16 active studies)
- A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight · Phase 3 · Eli Lilly and Company
- A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes · Phase 3 · Eli Lilly and Company
Mental health & behavior (11 active studies)
- Enhancing Veteran-Clinical Collaboration in VA PRRCs · VA Office of Research and Development
- Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder · Phase 1 · University of New Mexico
Eye & vision (7 active studies)
- CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
- A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK · Phase 3 · Kodiak Sciences Inc
Pediatric (6 active studies)
- Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome · HELP for NOWS Consortium
- Neonatal Platelet Transfusion Threshold Trial · NICHD Neonatal Research Network
Vaccines (5 active studies)
- Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation · Phase 2 · University of New Mexico
- A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose · Phase 3 · Pfizer
Common conditions studied in Albuquerque
- Breast Cancer (10 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Acute Myeloid Leukemia (8 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Endometrial Cancer (8 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Malignant Solid Neoplasm (7 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Hypertension (6 active studies). Hypertension research tests new antihypertensive drug classes, renal denervation devices, and fixed-dose combinations for resistant disease.
- Ovarian Cancer (6 active studies). Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease.
Leading research sponsors in Albuquerque
- National Cancer Institute (NCI)
- University of New Mexico
- NRG Oncology
- AstraZeneca
- SWOG Cancer Research Network
Local regulations and guidelines
Clinical trials in New Mexico are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Mexico research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Albuquerque. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Albuquerque
Hipa.ai aggregates every recruiting study in Albuquerque from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Albuquerque?
There are approximately 362 recruiting clinical trials in Albuquerque, New Mexico listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Albuquerque pay participants?
Most recruiting trials in Albuquerque compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Albuquerque?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Albuquerque?
The most common conditions under active study in Albuquerque include Breast Cancer (10), Acute Myeloid Leukemia (8), Endometrial Cancer (8), Malignant Solid Neoplasm (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Albuquerque?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Albuquerque on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Albuquerque?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Albuquerque?
Recruiting research sites in Albuquerque include University of New Mexico Cancer Center, University of New Mexico, Presbyterian Kaseman Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Albuquerque right now?
The largest active categories in Albuquerque are Cancer & tumors (144), Cardiovascular (25), Neurology & pain (20). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.